
    
      Study participants who received a first dose of recombinant Hep B vaccine at birth will
      receive either DTaP-IPV-Hep B-PRP~T combined vaccine at 2, 4, and 6 months of age + 3 doses
      of Hep B vaccine or Hep B vaccine (Euvax B®) at 1 and 6 months of age and DTaP IPV//PRP~T
      combined vaccine (Pentaxim™) at 2, 4, and 6 months of age, according to the official
      vaccination schedule for Hep B, DTaP, poliovirus, and Hib vaccinations in South Korea.
    
  